date:Jun 22, 2012
domised controlled trials (RCT) data that Cochrane reviews use for validation of the health benefits of nutrientswould guarantee not certainty but stagnation.
Policy makers must now accept that intervention trials designed to test the efficacy of powerful drugs on sick people are not always suitable for determining the benefits of nutrients.
The presence or absence of positive RCT data should not therefore be a gate-keeper criterion in the evaluation of nutrient or food claims,said DSM.
Kemin